Studies on mRNA and protein expression indicate that GLP-1 receptors are distributed throughout several tissues including the pancreas, kidney, stomach, heart and brain [1,3,10,11,12,13]
The 2026 EASO pharmacotherapy update formalised this evidence by ranking tirzepatide above semaglutide for obesity management, while simultaneously supporting semaglutide as the better-documented agent for liver fibrosis improvement in metabolic dysfunction-associated steatohepatitis (MASH), based on more mature phase 3 ESSENCE trial data [1]
When it comes to the "master antioxidant," glutathione, and its well-known partner, vitamin C, the way you take them determines the results you see
Harms J, Lautenshlager S, Minder C E, Minder E I (Jan 2009)
For research around the ankle, Sub-Q is the standard
Rocio Salas-Whalen, a board-certified endocrinologist, previously told TODAY